According to a market report by Lucintel, the future of the xerostomia therapeutic market in United States looks promising with opportunities in the over the counter and prescription applications. The xerostomia therapeutic market in United States is expected to reach an estimated $1 billion by 2031 with a CAGR of 3.5% from 2025 to 2031. The major drivers for this market are the growing demand for xerostomia treatments, the rising development of new and innovative xerostomia treatments, and the increasing awareness of xerostomia.
A more
than 150-page report to understand trends, opportunity and forecast in
xerostomia therapeutic market in United States to 2031 by product type
(artificial saliva, dentifrices, salivary stimulants, saliva substitutes,
drugs, and salivary pen), and application (over the counter and prescription).
Download
sample by clicking on xerostomia
therapeutic market in United States.
Lucintel
forecasts that, within the product type category, artificial saliva is expected
to witness the highest growth over the forecast period due to its significant
usage to perform similarly to natural saliva.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Xerostomia Therapeutic Market in Australia
Xerostomia Therapeutic Market in Brazil
Xerostomia Therapeutic Market in Canada
Xerostomia Therapeutic Market in Mexico
No comments:
Post a Comment